Dr. Omar Khan
Assistant Professor
Dr. Omar Khan
Assistant Professor
Educational Qualifications
Ph.D. in Molecular Medicine with Prof. Martin Bergo
MSc in Molecular Cell Biology
Entity
College of Health and Life Sciences
Biography
Dr. Khan did his Masters in Biochemistry from Karachi University, Pakistan before moving to Sweden. In Sweden, he did Masters in Cell Biology from Uppsala University, and then a Ph.D. in the lab of Prof. Martin Bergo, a protein lipidation expert. In Bergo's lab, he identified the biochemical importance of protein lipidation enzyme GGTase-I in immune cell function and refuted the popular idea that GGTase-I can be a therapeutic target against inflammatory conditions. After finishing his Ph.D., he moved to The Francis Crick Institute in Dr. Axel Behrens Lab, where he worked on identifying the posttranslational regulators of a tumour suppressor protein FBW7 and mechanisms of chemotherapy resistance in cancer.
Ph.D. in Molecular Medicine with Prof. Martin Bergo
Sahlgrenska Cancer Center Gothenburg University, Sweden
2007 – 2012
MSc in Molecular Cell Biology
Uppsala University, Sweden
2005 – 2006
MSc in Biochemistry
University of Karachi, Pakistan
2002 – 2003
Honorary Teaching Assistant
King’s College London, United Kindom
2018
Postdoctoral fellow with Dr. Axel Behrens
The Francis Crick Institute, United Kingdom
2013 - 2018
Postdoc with Prof. Martin Bergo
Sweden
2012
J Clin Invest. Feb 2018. (IF: 12.78)
Omar M. Khan, Joana Carvalho, Bradley Spencer-Dene, Richard Mitter, David Frith, Bram Snijders, Stephen A. Wood, and Axel Behrens
Circ Res. 2014 Oct 10;115(9):781-9. (IF: 13.96)
Sayin VI, Khan OM, Pehlivanoglu LE, Staffas A, Ibrahim MX, Asplund A, Agren P, Nilton A, Bergström G, Bergo MO, Borén J, Lindahl P.
Circulation Feb 2013. (IF: 19.3)
Khan OM, Akula MK, Skålen K, Karlsson C, Ståhlman M, Young SJ, Boren J and Bergo MO.
J Clin Invest. 2011 Feb 1;121(2):628–39. (IF: 12.78)
Khan OM, Ibrahim MX, Jonsson IM, Karlsson C, Liu M, Sjogren AKM, Olofsson FJ, Brisslert M, Andersson S, Ohlsson C, Hultén LM, Bokarewa M, and Bergo MO.
Leukemia 2010 Oct 26. (IF: 11.7)
Sjogren AK, Andersson KM, Khan O, Olofsson FJ, Karlsson C, Bergo MO.
Mol. Oncol. 2008 Jun;2(1):94–101.(IF: 5.33)
Linda Strandberg Ihrlund, Emma Hernlund, Omar Khan, Maria C. Shoshan
- July 2014–June 2017, VetenskapsRådet (VR) international postdoctoral fellow in molecular biology from Gothenburg University, Sweden. (Avtals ID: D0035901, 3.1 million SEK for 3-years)
- July 2013–June 2014, European Molecular Biology Organization’s (EMBO) postdoctoral fellow. (ID: ALTF 459-2013, GBP 28738 for 24-months; second year turned down)